Software patent

Lightwave Logic Secures U.S. Patent Issuance for Innovative Design Technique to Enable Foundry-Level Manufacture of Polymer Modulators

Retrieved on: 
Thursday, May 18, 2023

ENGLEWOOD, Colo., May 18, 2023 /PRNewswire/ -- Lightwave Logic, Inc. (NASDAQ: LWLG), a technology platform company leveraging its proprietary electro-optic polymers to transmit data at higher speeds with less power, today announced the issuance of a U.S. patent for a cutting-edge design technique, enhancing the performance of polymer modulators through the use of innovative polymer cladding design that is amenable for high-volume foundry fabrication when integrated with silicon photonics.

Key Points: 
  • The patent – entitled "Electro-optic polymer devices having high performance claddings and methods of preparing the same" (Patent No.
  • Dr. Michael Lebby, Chairman and Chief Executive Officer of Lightwave Logic, commented: "The issuance of this patent is another exciting IP milestone for Lightwave Logic, fortifying our intellectual property portfolio and showcasing our commitment to potential customers.
  • Concurrently, this new patent is helping us move forward with our commercial discussions through the enabling of enhanced performance and simplified manufacturing of our polymer modulators with silicon photonics.
  • As we continue our commercialization journey, I firmly believe that our continued innovation will create sustainable, long-term value for our shareholders."

Astrapi Awarded Three Patents to Growing Portfolio

Retrieved on: 
Monday, February 7, 2022

Generally, Astrapi Patents cover solutions to improve spectral efficiency, to secure signal transmissions, and to the identification, discrimination, and characterization of signals and other activity in a dynamic non-stationary electromagnetic spectrum.

Key Points: 
  • Generally, Astrapi Patents cover solutions to improve spectral efficiency, to secure signal transmissions, and to the identification, discrimination, and characterization of signals and other activity in a dynamic non-stationary electromagnetic spectrum.
  • Spiral Modulation enables Astrapi to construct signals from the sum of complex spirals rather than the customary sine waves.
  • Astrapi developed the use of Polynomial Symbol Waveform (PSW) alphabets, in which each symbol corresponds to a particular bandlimited polynomial.
  • Currently Astrapi has eighteen US Patents issued, with more pending and with corresponding international patent coverage.

DealCoachPro Secures Second Patent for its Exclusive Sales Technology

Retrieved on: 
Thursday, July 29, 2021

DELRAY BEACH, Fla., July 29, 2021 /PRNewswire-PRWeb/ --Sales technology software innovator, DealCoachPro announces Notice of Allowance for all claims in U.S. Patent Application No.

Key Points: 
  • DELRAY BEACH, Fla., July 29, 2021 /PRNewswire-PRWeb/ --Sales technology software innovator, DealCoachPro announces Notice of Allowance for all claims in U.S. Patent Application No.
  • "Getting our second software patent for DealCoachPro is an exciting accomplishment for our business and our team," said Erik Mintz, CEO and founder of DealCoachPro.
  • "We are the future of Enterprise selling, delivering modern tools for a company's most valuable deals, and this second patent further validates that our technology is like no other."
  • Today, most Enterprise sales teams use subjective and unreliable CRM Sales Stage and Close Dates to determine the probability of closing.

ZYUS Life Sciences Strengthens Software Patent Portfolio Supporting Clinical Development

Retrieved on: 
Thursday, July 22, 2021

ZYUS Life Sciences Inc. ("ZYUS"), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that its wholly owned U.S. subsidiary, ZYUS Life Sciences U.S. Ltd. (ZYUS U.S.), has received one patent allowance notification and two patent issuances from the United States Patent and Trademark Office (USPTO).

Key Points: 
  • ZYUS Life Sciences Inc. ("ZYUS"), a Canadian-based life sciences company leading scientific research and development in phyto-therapeutics, announced today that its wholly owned U.S. subsidiary, ZYUS Life Sciences U.S. Ltd. (ZYUS U.S.), has received one patent allowance notification and two patent issuances from the United States Patent and Trademark Office (USPTO).
  • Advancement of these software patents will further strengthen ZYUS clinical trial program by ensuring access to proprietary clinical and healthcare technology solutions.
  • This technology can be used to, among other things, identify, recruit and track participants in clinical trials.
  • About ZYUS Life Sciences Inc.
    ZYUS is a Canadian-based life sciences company focused on the global development and commercialization of innovative cannabinoid-based therapeutics and product candidates.

DealCoachPro Secures First Patent for its Exclusive Sales Technology

Retrieved on: 
Wednesday, March 3, 2021

DELRAY BEACH, Fla., March 3, 2021 /PRNewswire-PRWeb/ --DealCoachPro announced today being awarded its first Patent for its data-driven sales technology (Application No: 15/381,790).

Key Points: 
  • DELRAY BEACH, Fla., March 3, 2021 /PRNewswire-PRWeb/ --DealCoachPro announced today being awarded its first Patent for its data-driven sales technology (Application No: 15/381,790).
  • "Getting our first software patent for DealCoachPro is an exciting accomplishment for our business and our team," said Erik Mintz, CEO and founder of DealCoachPro.
  • "We've always believed our software to be a 'unicorn' in the deal coaching category, and this patent further validates that our technology is like no other."
  • "The patented DealCoachPro framework offers sales teams a unique way of dynamically assessing deal health and status.

SANUWAVE Health Significantly Strengthens Intellectual Property Portfolio with Multiple Important Patent Grants for Its Shockwave Technology

Retrieved on: 
Friday, November 6, 2020

"We believe that our intellectual property portfolio will provide our products with long-term market protection and will add significantly to our shareholder value."

Key Points: 
  • "We believe that our intellectual property portfolio will provide our products with long-term market protection and will add significantly to our shareholder value."
  • The following new patents related to the dermaPACE System have recently been granted to SANUWAVE Health:
    U.S. Patent 10,769,249, which is titled, Distributor Product Programming System.
  • This U.S. patent covers a system for controlling and monitoring service activities by authorized SANUWAVE distributors from around the world at their facilities.
  • In addition, SANUWAVE Health has more than 12 patent applications pending in the U.S. and foreign countries relating to the dermaPACE System.

Bots, Inc. Joins the Open Invention Network

Retrieved on: 
Wednesday, July 22, 2020

By joining the Open Invention Network community, BTZI is further demonstrating its support for developing open source software.

Key Points: 
  • By joining the Open Invention Network community, BTZI is further demonstrating its support for developing open source software.
  • By joining the Open Invention Network, we show our continued commitment to innovation, and support for patent non-aggression in open source projects.
  • Open Invention Network (OIN) is the largest patent non-aggression community in history and supports freedom of action in Linux as a key element of open source software (OSS).
  • Patents owned by Open Invention Network are similarly licensed royalty-free to any organization that agrees not to assert its patents against the Linux System.

FICO's Dr. Scott Zoldi Reaches a Data Science Milestone with 100th Software Patent Application

Retrieved on: 
Monday, August 5, 2019

Dr. Scott Zoldi has been an inventor on 100 patent applications for machine learning and AI software technologies and techniques.

Key Points: 
  • Dr. Scott Zoldi has been an inventor on 100 patent applications for machine learning and AI software technologies and techniques.
  • He has developed unique machine learning inventions for financial fraud, anti-money laundering, cybersecurity and collections, as well as fundamental data science capabilities.
  • Dr. Scott Zoldi, chief analytics officer at analytic software firm FICO, has reached a data science milestone with the filing of FICO's 100th software patent application listing him as an inventor.
  • Beyond the data science lab, Scott brings innovative thinking and enthusiasm to every customer conversation, industry speaking engagement and team meeting."